Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
Author:
Affiliation:
1. School of Pharmacy, Nanjing Medical University, Nanjing, China;
2. State Key Laboratory of Reproductive Medicine, Nanjing, China
Funder
National Natural Science Fund
Publisher
Informa UK Limited
Subject
Pharmaceutical Science,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/10717544.2018.1435746
Reference55 articles.
1. Therapeutic cancer targeting peptides
2. Ethanol-inducedin vitro invasion of breast cancer cells: The contribution of MMP-2 by fibroblasts
3. Treatment of HER2-overexpressing breast cancer
4. Disabling ErbB Receptors with Rationally Designed Exocyclic Mimetics of Antibodies: Structure−Function Analysis
5. Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Electrospun nanofibers: a promising paradigm for biomedical applications;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-04-08
2. Therapeutic Peptides, Proteins and their Nanostructures for Drug Delivery and Precision Medicine;ChemBioChem;2024-03-14
3. Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation;Expert Opinion on Drug Delivery;2024-03-03
4. MMP-2 Responsive Peptide Hydrogel-Based Nanoplatform for Multimodal Tumor Therapy;International Journal of Nanomedicine;2024-01
5. Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy;Journal of Controlled Release;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3